Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · New England Journal of Medicine · 2014 · 3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

Bruce Montgomery, Elahe A. Mostaghel, Robert L. Vessella et al. · Cancer Research · 2008 · 1.4K citations · Full text

Medicine, Endocrinology, Oncology +17

zCompositions — R package for multivariate imputation of left-censored data under a compositional approach

Javier Palarea‐Albaladejo, Josep Antoni Martín Fernández · Chemometrics and Intelligent Laboratory Systems · 2015 · 1K citations

Public Health, Biostatistics, Statistics +14

Androgen Levels Increase by Intratumoral <i>De novo</i> Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

Jennifer A. Locke, Emma S. Tomlinson Guns, Amy A. Lubik et al. · Cancer Research · 2008 · 739 citations · Full text

Medicine, Endocrinology, Oncology +17

Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)

Eric J. Small, Susan Halabi, Nancy A. Dawson et al. · Journal of Clinical Oncology · 2004 · 502 citations · Full text

Medicine, Oncology, Pharmacology +17